| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 8.87 | 0.11 (+1.26%) | 5.25 - 8.96 | 39.7 thousand |
Market data as of 11:19AM 05/22/13. Quotes are delayed by at least 15 min.
| Open | 8.80 |
|---|---|
| Previous Close | 8.76 |
| Day's Range | 8.78 - 8.92 |
| Market Cap | 254.1M |
| Avg Volume (10 Day) | 122.1K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | |
| Dividend Yield | 0.07 (3.16%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
The Female Health Company To Present At 14th Annual B. Riley & Co. Investor Conference On May 20, 2013
PR Newswire - Wednesday 05/15/2013 8:30 AM ET
Andrew Love Joins The Female Health Company Board of Directors
PR Newswire - Tuesday 05/14/2013 8:30 AM ET
The Female Health Company Reports 21% Rise in Net Revenues and 55% Increase in Operating Income for Second Quarter of FY2013
PR Newswire - Thursday 05/02/2013 8:30 AM ET
The Female Health Company To Report Second Quarter Operating Results on Thursday, May 2, 2013
PR Newswire - Thursday 04/25/2013 8:30 AM ET
| FHCO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 40.10% | |
| Net Income Growth (1yr) | 49.82% | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 6.61 |
| Company | Last | Change |
|---|---|---|
| Blyth Inc | 14.46 | +0.63% |
| Nutraceutical International Corp | 19.35 | -0.15% |
| United-Guardian Inc | 26.27 | -1.06% |
| Summer Infant Inc | 3.48 | -1.14% |
| Mannatech Inc | 11.71 | -2.58% |
Data is delayed by at least 15 min.